Form 4 for NUVB Nuvation Bio Inc.
Accepted 2026-04-21 16:34:07 ET · period of report 2026-04-17 · accession 0001937915-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-21 16:34 | 2026-04-17 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $1.94 | +50.0K | 68.0K | +278% | +$97.0K |
| DT | 2026-04-21 16:34 | 2026-04-17 | NUVB | Liu Dongfang | Chief MEDICAL Off | S - Sale+OE | $5.02 | -50.0K | 18.0K | -74% | -$251.0K |
| DT | 2026-04-21 16:34 | 2026-04-17 | NUVB | Liu Dongfang | Chief MEDICAL Off | M - OptEx | $0.00 | -50.0K | 430.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-04-17 | M | A | 50,000 | $1.94 | 68,000 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-04-17 | S | D | 50,000 | $5.02 | 18,000 | D | — | — | (F1) Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-04-17 | M | D | 50,000 | $0.00 | 430,000 | D | $1.94 · — to 2033-02-27 | 50,000 Class A Common Stock | (F3) Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date |